You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
AstraZeneca
Baxter
Moodys
Johnson and Johnson

Last Updated: May 15, 2021

DrugPatentWatch Database Preview

DIVALPROEX SODIUM Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Divalproex Sodium patents expire, and when can generic versions of Divalproex Sodium launch?

Divalproex Sodium is a drug marketed by Ajanta Pharma Ltd, Dr Reddys Labs Ltd, Mylan, Teva Pharms Usa, Zydus Pharms Usa Inc, Actavis Labs Fl Inc, Anchen Pharms, Apotex, Aurobindo Pharma Ltd, Celltrion, Invatech, Lupin, Orchid Hlthcare, Prinston Inc, Sun Pharm Inds, Teva, Unichem Labs Ltd, Upsher Smith Labs, Amneal Pharms, Amta, Cosette, Impax Labs, Lupin Ltd, Reddys, and Wockhardt. and is included in thirty-four NDAs.

The generic ingredient in DIVALPROEX SODIUM is divalproex sodium. There are eighteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the divalproex sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Divalproex Sodium

A generic version of DIVALPROEX SODIUM was approved as divalproex sodium by APOTEX on July 29th, 2008.

  Get Started for $10

Drug patent expirations by year for DIVALPROEX SODIUM
Drug Prices for DIVALPROEX SODIUM

See drug prices for DIVALPROEX SODIUM

Drug Sales Revenue Trends for DIVALPROEX SODIUM

See drug sales revenues for DIVALPROEX SODIUM

Recent Clinical Trials for DIVALPROEX SODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Universidad Autonoma de San Luis PotosíPhase 3
Puma Biotechnology, Inc.Phase 1/Phase 2
Virginia Commonwealth UniversityPhase 1/Phase 2

See all DIVALPROEX SODIUM clinical trials

Paragraph IV (Patent) Challenges for DIVALPROEX SODIUM
Tradename Dosage Ingredient NDA Submissiondate
DEPAKOTE ER TABLET, EXTENDED RELEASE;ORAL divalproex sodium 021168 2005-02-08
DEPAKOTE ER TABLET, EXTENDED RELEASE;ORAL divalproex sodium 021168 2004-05-03
DEPAKOTE TABLET, DELAYED RELEASE;ORAL divalproex sodium 018723

US Patents and Regulatory Information for DIVALPROEX SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa Inc DIVALPROEX SODIUM divalproex sodium TABLET, EXTENDED RELEASE;ORAL 078239-001 Feb 27, 2009 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Teva DIVALPROEX SODIUM divalproex sodium TABLET, DELAYED RELEASE;ORAL 076941-001 Jul 29, 2008 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Orchid Hlthcare DIVALPROEX SODIUM divalproex sodium TABLET, DELAYED RELEASE;ORAL 078853-001 Nov 25, 2008 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Upsher Smith Labs DIVALPROEX SODIUM divalproex sodium TABLET, DELAYED RELEASE;ORAL 078182-003 Jul 29, 2008 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Aurobindo Pharma Ltd DIVALPROEX SODIUM divalproex sodium TABLET, EXTENDED RELEASE;ORAL 202419-002 Jun 2, 2014 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Unichem Labs Ltd DIVALPROEX SODIUM divalproex sodium TABLET, DELAYED RELEASE;ORAL 079163-002 Apr 5, 2011 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Colorcon
McKinsey
Boehringer Ingelheim
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.